Literature DB >> 10695908

Cost comparison between three different general anaesthetic techniques for elective arthroscopy of the knee.

M Heidvall1, A Hein, S Davidson, J Jakobsson.   

Abstract

INTRODUCTION: We compared three anaesthetic techniques for elective knee arthroscopy with special reference to cost-effectiveness.
METHOD: Seventy-five ASA I-II patients having elective arthroscopy of the knee joint were randomised to receive an anaesthetic technique based on propofol, fentanyl for induction followed by sevoflurane in oxygen:nitrous oxide (1:2 l/min) for maintenance of one of two intravenous techniques: propofol alfentanil or propofol-remifentanil infusions in combination with oxygen in air.
RESULTS: All patients had an uncomplicated course. No differences were seen with regard to emergence, postoperative pain or emesis or time to discharge. The anaesthetic technique based on sevoflurane was associated with the lowest cost US$ 14.7 as compared to US$ 18 for the propfol/alfentanil and US$ 19.9 for the propofol/remifentanil technique, including both cost for wastage as well as premedication and other fixed drug costs. Looking only at the anaesthetic drugs consumed, the cost per minute was US$ 0.56 for sevoflurane/nitrous oxide as compared to US$ 0.68 and 0.63 per minute for the propofol/alfentanil and proprofol/remifentanil, respectively. When the cost for wastage was taken into account, the difference in mean anaesthetic drug cost was more pronounced: the sevoflurane anaesthetic technique US$ 0.58, the propofol/alfentanil US$ 0.74 and the propofol/remifentanil US$ 0.84 per minute respectively.
CONCLUSION: From a cost-minimisation point of view, anaesthesia based on sevoflurane in oxygen:nitrous oxide is the technique of choice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10695908     DOI: 10.1034/j.1399-6576.2000.440205.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  9 in total

Review 1.  Cost considerations in the use of anaesthetic drugs.

Authors:  I Smith
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

2.  Anaesthetic gas monitoring comparison between two side-stream monitors.

Authors:  H Heijbel; J Ostblom; M Brattwall; Jan Jakobsson
Journal:  J Clin Monit Comput       Date:  2010-03-18       Impact factor: 2.502

Review 3.  Remifentanil: a review of its use during the induction and maintenance of general anaesthesia.

Authors:  Lesley J Scott; Caroline M Perry
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 4.  Sevoflurance: approaching the ideal inhalational anesthetic. a pharmacologic, pharmacoeconomic, and clinical review.

Authors:  L Delgado-Herrera; R D Ostroff; S A Rogers
Journal:  CNS Drug Rev       Date:  2001

5.  Total intravenous anaesthesia: is it worth the cost?

Authors:  Ian Smith
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

6.  Knee arthroscopy with different anesthesia methods: a comparison of efficacy and cost.

Authors:  Magnus Forssblad; Eva Jacobson; Lars Weidenhielm
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2004-05-28       Impact factor: 4.342

7.  Anaesthetic Drug Choices of Senior Anaesthetists: An Observational Analysis of Medication Habits in a Tertiary Hospital.

Authors:  Laura Münst; Martin Schläpfer; Peter Biro
Journal:  Turk J Anaesthesiol Reanim       Date:  2018-09-04

8.  Cost-effectiveness of anesthesia maintained with sevoflurane or propofol with and without additional monitoring: a prospective, randomized controlled trial.

Authors:  Timea Bocskai; Csaba Loibl; Zoltan Vamos; Gabor Woth; Tihamer Molnar; Lajos Bogar; Laszlo Lujber
Journal:  BMC Anesthesiol       Date:  2018-07-28       Impact factor: 2.217

Review 9.  Health Economic Evaluations of Hip and Knee Interventions in Orthopaedic Sports Medicine: A Systematic Review and Quality Assessment.

Authors:  Codie A Primeau; Bryn O Zomar; Lyndsay E Somerville; Ishita Joshi; J Robert Giffin; Jacquelyn D Marsh
Journal:  Orthop J Sports Med       Date:  2021-03-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.